Case Report: Triple M (myocarditis-myositis-myasthenia gravis) Syndrome: A Severe Immune-Mediated Toxicity in Cancer Immunotherapy, a diagnostic challenge

  • Abstract
  • References
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

Case Report: Triple M (myocarditis-myositis-myasthenia gravis) Syndrome: A Severe Immune-Mediated Toxicity in Cancer Immunotherapy, a diagnostic challenge

ReferencesShowing 10 of 12 papers
  • Cite Count Icon 1
  • 10.1212/wnl.0000000000204031
Triple M Syndrome with Triple Seronegative Myasthenia Gravis presenting as a Non-ST Elevation Myocardial Infarction (P1-8.002)
  • Apr 25, 2023
  • Neurology
  • Octavio Carranza-Renteria + 6 more

  • Open Access Icon
  • Cite Count Icon 910
  • 10.1016/s0140-6736(20)32714-8
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
  • Jan 1, 2021
  • The Lancet
  • Paul Baas + 20 more

  • Cite Count Icon 655
  • 10.1016/j.annonc.2022.10.001
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  • Oct 18, 2022
  • Annals of Oncology
  • J Haanen + 11 more

  • Open Access Icon
  • PDF Download Icon
  • Cite Count Icon 86
  • 10.3389/fneur.2020.00634
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
  • Jul 16, 2020
  • Frontiers in Neurology
  • Yi-Te Huang + 4 more

  • Open Access Icon
  • 10.6004/jadpro.2021.12.3.14
Immune Checkpoint Inhibitors: Common Questions About Uncommon Adverse Events
  • Apr 1, 2021
  • Journal of the Advanced Practitioner in Oncology
  • Lisa Kottschade

  • Cite Count Icon 30
  • 10.7326/0003-4819-52-4-806
The place of corticotropin in the treatment of myasthenia gravis.
  • Apr 1, 1960
  • Annals of Internal Medicine
  • Leo D Freydberg

  • Open Access Icon
  • Cite Count Icon 2
  • 10.1097/cnd.0000000000000457
Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor Therapy.
  • Nov 13, 2023
  • Journal of Clinical Neuromuscular Disease
  • Nakul Katyal + 4 more

  • Cite Count Icon 177
  • 10.1212/wnl.52.3.629
Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis.
  • Feb 1, 1999
  • Neurology
  • A.I Qureshi + 8 more

  • Cite Count Icon 336
  • 10.1212/wnl.0000000000004359
Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan.
  • Aug 18, 2017
  • Neurology
  • Shigeaki Suzuki + 14 more

  • Cite Count Icon 30
  • 10.1007/s00415-020-10264-0
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.
  • Oct 16, 2020
  • Journal of neurology
  • Itay Lotan + 3 more

More from: Advances in Clinical Neuroscience & Rehabilitation
  • Open Access Icon
  • Research Article
  • 10.47795/nojk8575
Case Report: Triple M (myocarditis-myositis-myasthenia gravis) Syndrome: A Severe Immune-Mediated Toxicity in Cancer Immunotherapy, a diagnostic challenge
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Vishal Varghese + 2 more

  • Research Article
  • 10.47795/skak6135
Key considerations in setting up a therapeutic plasma exchange service for neurology patients
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Nicole Japzon + 10 more

  • Research Article
  • 10.47795/hbla7359
Navigating cerebral palsy from childhood to adulthood: The importance of effective transition
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Rebecca Walters + 2 more

  • Research Article
  • 10.47795/ciio7643
Head Injury: A strand in the ‘Weave’ of multiple health - morbidity in people in prison
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Tom Mcmillan

  • Research Article
  • 10.47795/frmt6123
Brown-Séquard, neurologist and father of endocrinology
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • John Pearce

  • Open Access Icon
  • Research Article
  • 10.47795/mtrh2044
The origins of “neurology” and “neurologist”
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Andrew J Larner

  • Open Access Icon
  • Research Article
  • 10.47795/rpod8631
Osler’s neurology
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Jms Pearce

  • Open Access Icon
  • Research Article
  • 10.47795/teki7506
John Hughlings Jackson (1835-1911): Discovery of further publications for inclusion in the Catalogue Raisonné
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Andrew J Larner

  • Research Article
  • 10.47795/ugnj5416
Functional neurological disorder rehabilitation in a community neurorehabilitation service: the Tower Hamlets model
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Will Parsons + 9 more

  • Research Article
  • 10.47795/kstw5069
Confabulation or hallucination? A case of bilateral occipital infarct blurring the boundaries between Charles Bonnet and Anton’s syndromes
  • Jan 1, 2025
  • Advances in Clinical Neuroscience & Rehabilitation
  • Killian Welch

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.

Search IconWhat is the difference between bacteria and viruses?
Open In New Tab Icon
Search IconWhat is the function of the immune system?
Open In New Tab Icon
Search IconCan diabetes be passed down from one generation to the next?
Open In New Tab Icon